The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Oxidative Stress and Endothelial Dysfunction in Aortas of Aged Spontaneously Hypertensive Rats by NOX1/2 Is Reversed by NADPH Oxidase Inhibition
Open accessAbstract
Arterial hypertension is associated with increased levels of reactive oxygen species, which may scavenge endothelium-derived NO and thereby diminish its vasorelaxant effects. However, the quantitatively relevant source of reactive oxygen species is unclear. Thus, this potential pathomechanism is not yet pharmacologically targetable. Several enzymatic sources of reactive oxygen species have been suggested: uncoupled endothelial NO synthase, xanthine oxidase, and NADPH oxidases. Here we show that increased reactive oxygen species formation in aortas of 12- to 14-month–old spontaneously hypertensive rats versus age-matched Wistar Kyoto rats is inhibited by the specific NADPH oxidase inhibitor VAS2870 but neither by the xanthine oxidase inhibitor oxypurinol nor the NO synthase inhibitor N G -nitro- l -arginine methyl ester. NADPH oxidase activity, as well as protein expression of its catalytic subunits, NOX1 and NOX2, was increased in the aortas of spontaneously hypertensive rats, whereas the expression of NOX4 protein, the most abundant NOX isoform, was not significantly changed. Impaired acetylcholine-induced relaxation of spontaneously hypertensive rat aortas was significantly improved by VAS2870. In conclusion, NOX1 and NOX2 but not NOX4 proteins are increased in aged spontaneously hypertensive rat aortas. Importantly, these NOX isoforms, in particular, ectopic expression of NOX1 in endothelial cells, appear to affect vascular function in an NADPH oxidase inhibitor-reversible manner. NADPH oxidases may, thus, be a novel target for the treatment of systemic hypertension.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“One study has related NOX4 to hyperglycemia and insulin resistance in mice (1012).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [1012]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,399
Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress
Cai, H., & Harrison, D. G. (2000) · Circulation Research · doi:10.1161/01.res.87.10.840 · Cited by 3,839
NAD(P)H Oxidase: Role in Cardiovascular Biology and Disease
Griendling, K. K., Sorescu, D., & Ushio-Fukai, M. (2000) · Circulation Research · doi:10.1161/01.res.86.5.494 · Cited by 2,886
Landmesser, U., Dikalov, S., Price, S. R., McCann, L., Fukai, T., Holland, S. M., Mitch, W. E., & Harrison, D. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200314172 · Cited by 1,660
Landmesser, U., Dikalov, S., Price, S. R., McCann, L. A., Fukai, T., Holland, S. M., Mitch, W. E., & Harrison, D. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci14172 · Cited by 1,652
Mechanisms Underlying Endothelial Dysfunction in Diabetes Mellitus
Hink, U., Li, H., Mollnau, H., Oelze, M., Matheis, E., Hartmann, M., Skatchkov, M. P., Thaiss, F., Stahl, R. A. K., Warnholtz, A., et al. (2001) · Circulation Research · doi:10.1161/01.res.88.2.e14 · Cited by 1,191
Lassègue, B., Sorescu, D., Szöcs, K., Yin, Q., Akers, M., Zhang, Y., Grant, S. L., Lambeth, J. D., & Griendling, K. K. (2001) · Circulation Research · doi:10.1161/hh0901.090299 · Cited by 839
Mitochondrial Dysfunction in Atherosclerosis
Madamanchi, N. R., & Runge, M. S. (2007) · Circulation Research · doi:10.1161/01.res.0000258450.44413.96 · Cited by 804
Zhao, H., Kalivendi, S., Zhang, H., Joseph, J., Nithipatikom, K., Vásquez-Vivar, J., & Kalyanaraman, B. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(03)00142-4 · Cited by 803
Does superoxide underlie the pathogenesis of hypertension?
Nakazono, K., Watanabe, N., Matsuno, K., Sasaki, J., Sato, T., & Inoue, M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.10045 · Cited by 746
Cited by
Sorted by citations
Incalza, M. A., D’Oria, R., Natalicchio, A., Perrini, S., Laviola, L., & Giorgino, F. (2017) · Vascular Pharmacology · doi:10.1016/j.vph.2017.05.005 · Cited by 1,419
NADPH oxidases: An overview from structure to innate immunity-associated pathologies
Panday, A., Sahoo, M. K., Osorio, D., & Batra, S. (2015) · Cellular & Molecular Immunology · doi:10.1038/cmi.2014.89 · Cited by 944
Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets
Drummond, G. R., Selemidis, S., Griendling, K. K., & Sobey, C. G. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3403 · Cited by 899
Vascular nitric oxide: Beyond eNOS
Zhao, Y., Vanhoutte, P. M., & Leung, S. W. S. (2015) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2015.09.002 · Cited by 875
Biochemistry, Physiology, and Pathophysiology of NADPH Oxidases in the Cardiovascular System
Lassegue, B. P., Martín, A. S., & Griendling, K. K. (2012) · Circulation Research · doi:10.1161/circresaha.111.243972 · Cited by 780
Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation
Tejero, J., Shiva, S., & Gladwin, M. T. (2019) · Physiological Reviews · doi:10.1152/physrev.00036.2017 · Cited by 541
Redox Signaling in Cardiac Physiology and Pathology
Burgoyne, J. R., Mongue‐Din, H., Eaton, P., & Shah, A. M. (2012) · Circulation Research · doi:10.1161/circresaha.111.255216 · Cited by 495
Self-citationNADPH Oxidases in Vascular Pathology
Konior, A., Schramm‐Luc, A., Cześnikiewicz‐Guzik, M., & Guzik, T. J. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5607 · Cited by 464
The NOX toolbox: validating the role of NADPH oxidases in physiology and disease
Altenhöfer, S., Kleikers, P. W. M., Radermacher, K. A., Scheurer, P., Rob Hermans, J. J., Schiffers, P., Ho, H., Wingler, K., & Schmidt, H. H. H. W. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1010-9 · Cited by 371
Self-citationVascular biology of ageing—Implications in hypertension
Harvey, A., Montezano, A. C., & Touyz, R. M. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.04.011 · Cited by 330
Endothelial NADPH oxidases: which NOX to target in vascular disease?
Drummond, G. R., & Sobey, C. G. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2014.06.012 · Cited by 315
Montezano, A. C. I., & Touyz, R. M. (2011) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2011.00785.x · Cited by 320
Mechanisms and consequences of endothelial nitric oxide synthase dysfunction in hypertension
Li, Q., Youn, J.-Y., & Cai, H. “. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000587 · Cited by 244
Antioxidants in Translational Medicine
Schmidt, H. H. H. W., Stocker, R., Vollbracht, C., Paulsen, G., Riley, D. P., Daiber, A., & Cuadrado, A. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6393 · Cited by 232
Self-citationRedox signaling in cardiovascular health and disease
Madamanchi, N. R., & Runge, M. S. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.04.001 · Cited by 227
Dikalov, S., Itani, H. A., Richmond, B. W., Arslanbaeva, L., Vergeade, A., Rahman, S. M. J., Boutaud, O. G., Blackwell, T. S., Massion, P. P., Harrison, D. G., et al. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00595.2018 · Cited by 221
Antihypertensive effects of probiotics Lactobacillus strains in spontaneously hypertensive rats
Gómez‐Guzmán, M., Toral, M., Romero, M., Jiménez, R., Galindo, P., Sánchez, M., Zarzuelo-Romero, M. J., Olivares, M. M., Gálvez, J., & Duarte, J. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500290 · Cited by 216
From form to function: the role of Nox4 in the cardiovascular system
Chen, F., Haigh, S. B., Barman, S. A., & Fulton, D. J. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00412 · Cited by 181
NADPH oxidase-derived reactive oxygen species: involvement in vascular physiology and pathology
Manea, A. (2010) · Cell and Tissue Research · doi:10.1007/s00441-010-1060-y · Cited by 169
Muñoz, M., López‐Oliva, M. E., Rodríguez, C., Martínez, M. P., Medina, J. S., Sánchez, A., Climent, B., Benedito, S., García‐Sacristán, A., Rivera, L., et al. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101330 · Cited by 148
Reactive Oxygen-Related Diseases: Therapeutic Targets and Emerging Clinical Indications
Casas, A. I., Dao, V. T.-V., Daiber, A., Maghzal, G. J., Di Lisa, F., Kaludercic, N., Leach, S., Cuadrado, A., Jaquet, V., Seredenina, T., et al. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2015.6433 · Cited by 136
Self-citationNADPH oxidases and vascular remodeling in cardiovascular diseases
García‐Redondo, A. B., Aguado, A., Briones, A. M., & Salaíces, M. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.10.015 · Cited by 139
Langbein, H., Brunssen, C., Hofmann, A., Cimalla, P., Brux, M., Bornstein, S. R., Deussen, A., Koch, E., & Morawietz, H. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv564 · Cited by 133
Anti-Inflammatory and Proliferative Properties of Luteolin-7-O-Glucoside
Stefano, A. D., Caporali, S., Daniele, N. D., Rovella, V., Cardillo, C., Schinzari, F., Minieri, M., Pieri, M., Candi, E., Bernardini, S., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031321 · Cited by 130
The NADPH Oxidase Family and its Inhibitors
Kleniewska, P., Piechota-Polańczyk, A., Skibska, B., & Gorąca, A. (2012) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-012-0176-z · Cited by 131
Smillie, S.-J., King, R., Kodji, X., Outzen, E. M., Pozsgai, G., Fernandes, E. S., Marshall, N. J., de Winter, P., Heads, R. J., Dessapt-Baradez, C., et al. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.02517 · Cited by 121
Self-citationRegulation of NAD(P)H oxidases by AMPK in cardiovascular systems
Song, P., & Zou, M. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.01.025 · Cited by 122
Nox1, 2, 4, 5: Counting out oxidative stress
Wingler, K., Hermans, J., Schiffers, P., Moens, A., Paul, M., & Schmidt, H. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01249.x · Cited by 113
Self-citationNOX Isoforms and Reactive Oxygen Species in Vascular Health
Touyz, R. M., Briones, A. M., Sedeek, M. H., Burger, D. E., & Montezano, A. C. (2011) · Molecular Interventions · doi:10.1124/mi.11.1.5 · Cited by 117
Knock, G. A. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.09.029 · Cited by 110
Lu, C., Yang, Y., Li, C., Liu, K., Lii, C., & Chen, H. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.06.024 · Cited by 107
NADPH oxidases: redox regulation of cell homeostasis and disease
Kračun, D., Lopes, L. R., Cifuentes-Pagano, E., & Pagano, P. J. (2025) · Physiological Reviews · doi:10.1152/physrev.00034.2023 · Cited by 115
Jin, L., Piao, Z. H., Sun, S., Liu, B., Kim, G. R., Seok, Y. M., Lin, M. Q., Ryu, Y., Choi, S. Y., Kee, H. J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-15925-1 · Cited by 104
The opposing roles of NO and oxidative stress in cardiovascular disease
Ritchie, R. H., Drummond, G. R., Sobey, C. G., Silva, T. M. D., & Kemp‐Harper, B. K. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.12.017 · Cited by 99
Meijles, D. N., Sahoo, S., Ghouleh, I. A., Amaral, J. H., Bienes-Martínez, R., Knupp, H. E., Attaran, S., Sembrat, J., Nouraie, M. S., Rojas, M. M., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aaj1784 · Cited by 100
Tran, V., Silva, T. M. D., Sobey, C. G., Lim, K., Drummond, G. R., Vinh, A., & Jelinic, M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00148 · Cited by 94
NADPH oxidase inhibitors: a decade of discovery from Nox2ds to HTS
Cifuentes-Pagano, E., Csányi, G., & Pagano, P. J. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1009-2 · Cited by 94
Romero, M., Toral, M., Gómez‐Guzmán, M., Jiménez, R., Galindo, P., Sánchez, M., Olivares, M. M., Gálvez, J., & Duarte, J. (2015) · Food & Function · doi:10.1039/c5fo01101a · Cited by 91
NOXious signaling in pain processing
Kallenborn-Gerhardt, W., Schröder, K., Geißlinger, G., & Schmidtko, A. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.11.001 · Cited by 93
Differential regulation of Nox1, Nox2 and Nox4 in vascular smooth muscle cells from WKY and SHR
Briones, A. M., Tabet, F., Callera, G. E., Montezano, A. C. I., Yogi, Á., He, Y., Quinn, M. T., Salaíces, M., & Touyz, R. M. (2011) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2011.02.001 · Cited by 89
The role of oxysterols in vascular ageing
Gargiulo, S., Gamba, P., Testa, G., Leonarduzzi, G., & Poli, G. (2015) · The Journal of Physiology · doi:10.1113/jp271168 · Cited by 86
Chen, Z., Yu, J., Fu, M., Dong, R., Yang, Y., Luo, J., Hu, S., Li, W., Xu, X., & Tu, L. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113951 · Cited by 85
Linking RAGE and Nox in diabetic micro- and macrovascular complications
Koulis, C., Watson, A. M. D., Gray, S. P., & Jandeleit-Dahm, K. A. M. (2015) · Diabetes & Metabolism · doi:10.1016/j.diabet.2015.01.006 · Cited by 86
Jin, H., Song, B., Oudit, G. Y., Davidge, S. T., Yu, H., Jiang, Y., Gao, P., Zhu, D., Ning, G., Kassiri, Z., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038502 · Cited by 83
Dorfmüller, P., Chaumais, M., Giannakouli, M., Durand–Gasselin, I., Raymond, N., Fadel, É., Mercier, O. M., Charlotte, F., Montani, D., Simonneau, G., et al. (2011) · Respiratory Research · doi:10.1186/1465-9921-12-119 · Cited by 83
Drug Treatment of Hypertension: Focus on Vascular Health
Cameron, A. C., Lang, N. N., & Touyz, R. M. (2016) · Drugs · doi:10.1007/s40265-016-0642-8 · Cited by 85
Roy, B. (2025) · Medical Sciences · doi:10.3390/medsci13030087 · Cited by 103
Microvascular NADPH oxidase in health and disease
Li, Y., & Pagano, P. J. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.02.049 · Cited by 79
Isoform-selective NADPH oxidase inhibitor panel for pharmacological target validation
Dao, V. T.-V., Elbatreek, M. H., Altenhöfer, S., Casas, A. I., Pachado, M. P., Neullens, C. T., Knaus, U. G., & Schmidt, H. H. H. W. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.12.038 · Cited by 81
Self-citationRenal Dopamine Receptors, Oxidative Stress, and Hypertension
Cuevas, S., Villar, V. A. M., José, P. A., & Armando, I. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140917553 · Cited by 77
Maiocchi, S. L., Ku, J., Thai, T., Chan, E., Rees, M. D., & Thomas, S. R. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107711 · Cited by 78
Nox1 in cardiovascular diseases: regulation and pathophysiology
Gimenez, M., Schickling, B., Lopes, L. R., & Miller, F. J. (2015) · Clinical Science · doi:10.1042/cs20150404 · Cited by 77
Octavia, Y., Rocca, H. B., & Moens, A. L. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.10.482 · Cited by 75
NADPH oxidase inhibitors: a patent review
Kim, J., Neupane, G. P., Lee, E. S., Jeong, B., Park, B. C., & Thapa, P. (2011) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2011.584870 · Cited by 70
Hamza, S. M., & Dyck, J. R. B. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00292 · Cited by 76
Sureda, A., Bibiloni, M. D. M., Martorell, M., Buil‐Cosiales, P., Martí, A., Pons, A., Tur, J. A., Martínez‐González, M. Á., & PREDIMED Study Investigators (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600450 · Cited by 70
Bretón-Romero, R., González de Orduña, C., Romero, N., Sánchez-Gómez, F. J., de Álvaro, C., Porras, A., Rodríguez-Pascual, F., Laranjinha, J., Radi, R., & Lamas, S. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.12.026 · Cited by 66
TRPV1 activation prevents high-salt diet-induced nocturnal hypertension in mice
Hao, X., Chen, J., Luo, Z., He, H., Yu, H., Ma, L., Ma, S., Zhu, T., Liu, D., & Zhu, Z. (2011) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-011-0921-x · Cited by 63
Higashi, Y., Pandey, A. K., Goodwin, B., & Delafontaine, P. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.12.005 · Cited by 63
Pinheiro, L. C., Oliveira‐Paula, G. H., Portella, R. L., Guimarães, D. A., de Angelis, C. D., & Tanus-Santos, J. E. (2016) · Redox Biology · doi:10.1016/j.redox.2016.08.001 · Cited by 63
Current status of NADPH oxidase research in cardiovascular pharmacology
Álvarez, E., Rodiño-Janeiro, Paradela-Dobarro, Castiñeiras-Landeira, Raposeiras‐Roubín, S., & González‐Juanatey, J. R. (2013) · Vascular Health and Risk Management · doi:10.2147/vhrm.s33053 · Cited by 64
Endothelial and vascular smooth muscle dysfunction in hypertension
de Oliveira, M. G., Nadruz, W., & Mónica, F. Z. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115263 · Cited by 64
Mistry, R. K., Murray, T. V., Prysyazhna, O. D., Martin, D., Burgoyne, J. R., Santos, C. X. C., Eaton, P., Shah, A. M., & Brewer, A. C. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.685578 · Cited by 60
Self-citationRoos, C. M., Hagler, M., Zhang, B., Oehler, E. A., Arghami, A., & Miller, J. D. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00735.2012 · Cited by 54
Liu, B., Luo, X., Yang, Z., Zhang, J.-J., Li, T., Zhang, X., Ma, Q., Zhang, G., Hu, C., & Peng, J. (2014) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000082 · Cited by 54
Cao, Y., Zhang, Y., Wang, N., & He, L. (2014) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2014.04.006 · Cited by 53
dos Santos, R. L., Dellacqua, L. O., Delgado, N. T. B., Rouver, W. D. N., Podratz, P. L., Freitas‐Lima, L. C., Cabral-Piccin, M. P., Meyrelles, S. S., Mauad, H., Graceli, J. B., et al. (2016) · Journal of Toxicology and Environmental Health · doi:10.1080/15287394.2016.1213690 · Cited by 56
Ling, W. C., Liu, J., Lau, C. W., Murugan, D. D., Mustafa, M. R., & Huang, Y. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.04.007 · Cited by 53
Nox and Inflammation in the Vascular Adventitia
Meijles, D. N., & Pagano, P. J. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.03622 · Cited by 54
Galindo, P., González‐Manzano, S., Zarzuelo-Romero, M. J., Gómez‐Guzmán, M., Quintela, A. M., Paramás, A. M. G., Santos‐Buelga, C., Pérez‐Vizcaíno, F., Duarte, J., & Jiménez, R. (2012) · Food & Function · doi:10.1039/c2fo10268d · Cited by 50
Norton, C. E., Broughton, B. R. S., Jernigan, N. L., Walker, B. R., & Resta, T. C. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4836 · Cited by 49
Sancho, P., & Fabregat, I. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.01.007 · Cited by 48
Rezende, F., Moll, F., Walter, M., Helfinger, V., Hahner, F., Janetzko, P., Ringel, C., Weigert, A., Fleming, I., Weißmann, N., et al. (2017) · Redox Biology · doi:10.1016/j.redox.2017.11.014 · Cited by 42
Fenyo, I. M., Albulescu, I. C., Raicu, M., & Manea, A. (2011) · Vascular Pharmacology · doi:10.1016/j.vph.2011.03.006 · Cited by 40
Vázquez, A., Sánchez-Rodríguez, E., Vargas, F., Montoro-Molina, S., Romero, M., Espejo-Calvo, J. A., Vílchez, P., Jaramillo, S., Olmo‐García, L., Carrasco‐Pancorbo, A., et al. (2019) · Nutrients · doi:10.3390/nu11081728 · Cited by 41
Iyonaga, T., Shinohara, K., Mastuura, T., Hirooka, Y., & Tsutsui, H. (2019) · Hypertension Research · doi:10.1038/s41440-019-0333-4 · Cited by 41
Nox enzymes and oxidative stress in atherosclerosis
Simionescu, M. (2012) · Frontiers in Bioscience-Scholar · doi:10.2741/s291 · Cited by 39
Apocynin reduces blood pressure and restores the proper function of vascular endothelium in SHR
Perassa, L. A., Graton, M. E., Potje, S. R., Troiano, J. A., Lima, M. S., do Vale, G. T., Pereira, A. A. F., Nakamune, A. C. D. M. S., Sumida, D. H., Tirapelli, C. R., et al. (2016) · Vascular Pharmacology · doi:10.1016/j.vph.2016.06.005 · Cited by 39
Wong, P. S., Randall, M. D., & Roberts, R. E. (2015) · Vascular Pharmacology · doi:10.1016/j.vph.2015.04.001 · Cited by 39
Li, Y., Kračun, D., Dustin, C. M., Massry, M. E., Yuan, S. S., Goossen, C., DeVallance, E., Sahoo, S., Hilaire, C. S., Gurkar, A. U., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2015666118 · Cited by 36
Impaired Vascular Redox Signaling in the Vascular Complications of Obesity and Diabetes Mellitus
Akoumianakis, I., & Antoniades, C. A. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7421 · Cited by 37
Wang, X., Zhao, S., Su, M., Sun, L., Zhang, S., Wang, D., Liu, Z., Yuan, Y., Liu, Y., & Li, Y. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.04.097 · Cited by 35
Bastian, P., Lang, K. S., Niggemann, B., Zaenker, K. S., & Entschladen, F. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4391-6 · Cited by 34
Silva, B. R., Pernomian, L., Grando, M. D., Amaral, J. H., Tanus-Santos, J. E., & Bendhack, L. M. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.09.036 · Cited by 33
Dong, Q., Xing, W., Fu, F., Liu, Z., Wang, J., Liang, X., Zhou, X., Yang, Q., Zhang, W., Gao, F., et al. (2016) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x16500786 · Cited by 33
Mora‐Pale, M., Kwon, S., Linhardt, R. J., & Dordick, J. S. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.12.015 · Cited by 32
Thengchaisri, N., Hein, T. W., Ren, Y., & Kuo, L. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.07.014 · Cited by 31
Si, L.-Y.-N., Kamisah, Y., Ramalingam, A. R., Lim, Y. C., Budin, S. B., & Zainalabidin, S. (2017) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2016-0506 · Cited by 31
Exacerbation of endothelial dysfunction during the progression of diabetes: role of oxidative stress
Huang, A., Yang, Y., Fehér, A., Bagi, Z. A., Kaley, G., & Sun, D. (2012) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00699.2011 · Cited by 30
Anti-Inflammatory Effects of Peripheral Dopamine
Moore, S. C., de Castro, P. A. S. V., Yaqub, D., José, P. A., & Armando, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813816 · Cited by 32
The Pathophysiological Role of NOX2 in Hypertension and Organ Damage
Forte, M., Nocella, C., FALCO, E. D., Palmerio, S., Schirone, L., Valenti, V., Frati, G., Carnevale, R., & Sciarretta, S. (2016) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-016-0175-y · Cited by 29
Cardiovascular protection by Nox4
Morawietz, H. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvx252 · Cited by 28
Pang, Z., Sun, X., Bai, R., Han, M.-Z., Zhang, Y., Wu, W., Zhang, Y., Lai, B., Zhang, Y., Wang, Y., et al. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04623-5 · Cited by 27
Vendrov, A. E., Stevenson, M., Lozhkin, A. P., Hayami, T., Holland, N. A., Yang, X., Moss, N., Pan, H., Wickline, S. A., Stockand, J. D., et al. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0047 · Cited by 26
Androwiki, A. C. D., Camargo, L. L., Sartoretto, S., Couto, G. K., Ribeiro, I. M. R., Veríssimo-Filho, S., Rossoni, L. V., & Lopes, L. R. (2015) · Frontiers in Chemistry · doi:10.3389/fchem.2015.00024 · Cited by 25
Hu, X., & Zhang, L. (2022) · Antioxidants · doi:10.3390/antiox11122432 · Cited by 22
ANALES DE LA REAL ACADEMIA NACIONAL DE FARMACIA
Aguado, A., Avendaño, M. S., Briones, A. M., & Salaíces, M. (2015) · Cited by 25
Functional Role of Nox4 in Autophagy
Forte, M., Palmerio, S., Yee, D., Frati, G., & Sciarretta, S. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-55330-6_16 · Cited by 25
Kwok, J. M. F., Ma, C. C.-H., & Ma, S. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.10.003 · Cited by 24
Fukuda, T., Kuroda, T., Kono, M., Miyamoto, T., Tanaka, M., & Matsui, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088975 · Cited by 24
Metadata
- Authors
- Wind, S., Beuerlein, K., Armitage, M. E., Taye, A., Kumar, A. H. S., Janowitz, D., Neff, C., Shah, A. M., Wingler, K., & Schmidt, H. H. H. W.
- Affiliations
- King's College London (GB)
- Venue
- Hypertension
- Published
- 2010-09
- Volume
- 56
- Issue
- 3
- Pages
- 490-497
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2116462934
- Cited by
- 181
- References
- 56
- Citations by year
- 2026: 5 · 2025: 3 · 2024: 6 · 2023: 5 · 2022: 10 · 2021: 6 · 2020: 7 · 2019: 13 · 2018: 5 · 2017: 11 · 2016: 13 · 2015: 23 · 2014: 18 · 2013: 13 · 2012: 23
- FWCI
- 11.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Hypertension (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, other-oa)
- Research Portal (King's College London) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Funders
- British Heart Foundation (RG/08/011/25922)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Keywords
- NADPH oxidase, NOX1, NOX2, NOX4, oxidative stress, endothelial dysfunction, spontaneously hypertensive rats, hypertension, aging, reactive oxygen species, VAS2870, acetylcholine-induced relaxation, endothelial nitric oxide, xanthine oxidase, endothelial nitric oxide synthase, aorta
- MeSH terms
- NADPH Oxidase 1, NADPH Oxidase 2, Acetylcholine, Aging, Analysis of Variance, Animals, Aorta, Endothelium, Vascular, Fluorescent Antibody Technique, Hypertension, Male, Membrane Glycoproteins, NADH, NADPH Oxidoreductases, Rats, Inbred SHR, Rats, Inbred WKY, Xanthine Oxidase, Blotting, Western, Reactive Oxygen Species, Oxidative Stress, NADPH Oxidases, Rats, Nitric Oxide Synthase Type III
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review